PPARγ is encoded by the gene PPARG, and agonists of PPARG (e.g., IFC305 and pioglitazone) obstruct liver fibrosis by inhibiting HSC activation and regulating the expression of adipogenic- and fibrogenic-related genes. Here, PPARG is linked to Hepatic fibrosis.